Barimbao, Mary Sweet F.

HRN: 09-50-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2026
CEFUROXIME 750MG (VIAL)
06/08/2026
06/15/2026
IV
750mg
Q8hours
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: